Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern
HCG vs Semaglutide: Comparing Weight Loss Treatments In the quest for effective weight loss solutions, Semaglutide and HCG have emerged as popular options, each with distinct mechanisms and benefits
Feeling low energy on a caloric deficit is normal
Long acting agonists appear to penetrate permeable areas of the blood-brain barrier and act directly on neurons with GLP-1R in the paraventricular nucleus (PVN) and Area Postrema (56, 102, 105)
Leinonen, E
Understanding how semaglutide works can guide you in making an informed decision about your weight loss strategy